Cerebral glucose metabolism and striatal 18F-Dopa uptake by PET in cases of chorea with or without dementia

Journal of the Neurological Sciences

Volumn 115, Issue 2, 1993, Pages 153-157

  Otsuka, Makoto ^a   Ichiya, Yuichi ^a   Kuwabara, Yasuo ^a   Hosokawa, Shinichi ^a   Sasaki, Masayuki ^a   Fukumura, Toshimitsu ^a   Masuda, Kouji ^a   Goto, Ikuo ^a   Kato, Motohiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

18F Dopa uptake; Chorea; Choreoacanthocytosis; Dementia; Glucose metabolism; Hemichorea; Huntington's disease; Positron emission tomography

Indexed keywords

6 FLUORODOPA F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEMENTIA; FEMALE; GLUCOSE UTILIZATION; HEMISPHERE; HUMAN; HUNTINGTON CHOREA; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; BRAIN; CAUDATE NUCLEUS; CHOREA; CORPUS STRIATUM; DEMENTIA; DIHYDROXYPHENYLALANINE; FEMALE; FLUORINE RADIOISOTOPES; GLUCOSE; HUMAN; MALE; MIDDLE AGE; PUTAMEN; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0027481846     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(93)90218-N     Document Type: Article

References (18)

1. Huntington's chorea
2. Alterations of brain neurotransmitter receptor binding in Huntington's chorea
3. Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease
4. The clinical assessment of dementia in the aged; a dementia screening scale for psychogeriatric patients
5. Positron emission tomography in the early diagnosis of Huntington's disease
6. Positron emission tomography in cases of chorea with different underlying diseases
7. Design and evaluation of the positron emission tomograph: HEADTOME III
8. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease
9. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease
10. Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography
11. Cortical glucose metabolism in Huntington's disease
12. Cerebral glucose utilization and blood flow in Huntington's disease: symptomatic and at-risk subjects
13. Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy
14. 18F-Dopa uptake: difference in Parkinson's disease and atypical Parkinsonism
15. Evaluation of ratio method and graphical analyses for estimating nigrostriatal function in F-Dopa PET studies with or without carbidopa
16. Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia
17. Neurochemical alterations in Huntington's chorea
18. PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline